Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts
- PMID: 20463646
- DOI: 10.1097/TP.0b013e3181dfa694
Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts
Abstract
Background: There is increasing evidence for a role for autoimmunity in transplant rejection. It has previously been shown that autoantibodies to vimentin (Vim) accelerate acute rejection of murine cardiac allografts. We have investigated whether autoimmunity to Vim contributes to development of cardiac allograft vasculopathy (CAV).
Methods: Two well-established minor mismatch murine models of CAV were used, transplantation of 129/sv hearts into T-cell-depleted C57Bl/6 (B6) recipients and transplantation of FVB hearts into nonimmunosuppressed DBA/1 recipients. Recipients were immunized with recombinant mouse Vim in complete Freunds adjuvant, and controls received hen egg lysozyme 2 weeks before transplantation. T cell and antibody responses to Vim were assessed by ELISPOT and ELISA, respectively. CAV within transplanted hearts was assessed by quantitative morphometry of occluded vessels, presence of smooth muscle cells, deposition of C3d, and confocal microscopy.
Results: Allografts were harvested from B6 recipients at days 30 and 45 and from DBA/1 recipients at days 18 and 35. At all days, there was significantly more intimal occlusion of arteries of Vim -immunized mice than controls. There was significantly more smooth muscle cell alpha actin in vessels from Vim-immunized mice, and more C3d deposited in hearts from Vim-immunized mice. Confocal microscopy demonstrated colocalization of Vim with C3d on endothelial cells, leukocytes, and platelets in allogeneic but not syngeneic hearts. Serum from Vim-immunized mice, but not controls, caused platelet/leukocyte conjugation when added to mouse leukocytes.
Conclusion: The autoimmune response to Vim accelerates CAV progression in these minor-mismatched models.
Comment in
-
Autoantibody and transplant vasculopathy: the enemy within.Transplantation. 2010 Jul 15;90(1):2-3. doi: 10.1097/TP.0b013e3181dfa6b1. Transplantation. 2010. PMID: 20463645 No abstract available.
Similar articles
-
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.Am J Pathol. 2007 Apr;170(4):1415-27. doi: 10.2353/ajpath.2007.060728. Am J Pathol. 2007. PMID: 17392180 Free PMC article.
-
Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.Transplantation. 2003 Jul 15;76(1):84-91. doi: 10.1097/01.TP.0000072013.21336.64. Transplantation. 2003. PMID: 12865791
-
In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging.Circulation. 2005 Aug 30;112(9 Suppl):I105-10. doi: 10.1161/CIRCULATIONAHA.104.524777. Circulation. 2005. PMID: 16159800
-
Humoral autoimmunity and transplant vasculopathy: when allo is not enough.Transplantation. 2010 Jul 27;90(2):113-20. doi: 10.1097/TP.0b013e3181e25a59. Transplantation. 2010. PMID: 20531074 Review.
-
Role of anti-vimentin antibodies in allograft rejection.Hum Immunol. 2013 Nov;74(11):1459-62. doi: 10.1016/j.humimm.2013.06.006. Epub 2013 Jun 15. Hum Immunol. 2013. PMID: 23777935 Free PMC article. Review.
Cited by
-
Autoimmune Reactivity in Graft Injury: Player or Bystander?Curr Transplant Rep. 2015 Sep;2(3):211-221. doi: 10.1007/s40472-015-0068-3. Epub 2015 Jul 7. Curr Transplant Rep. 2015. PMID: 29057202 Free PMC article.
-
Exosomes expressing the self-antigens myosin and vimentin play an important role in syngeneic cardiac transplant rejection induced by antibodies to cardiac myosin.Am J Transplant. 2018 Jul;18(7):1626-1635. doi: 10.1111/ajt.14650. Epub 2018 Feb 14. Am J Transplant. 2018. PMID: 29316217 Free PMC article.
-
Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.J Immunol. 2011 Jul 15;187(2):1023-30. doi: 10.4049/jimmunol.1004195. Epub 2011 Jun 15. J Immunol. 2011. PMID: 21677143 Free PMC article.
-
Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis.Front Immunol. 2015 Jan 12;5:684. doi: 10.3389/fimmu.2014.00684. eCollection 2014. Front Immunol. 2015. PMID: 25628623 Free PMC article. Review.
-
P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes.J Clin Invest. 2018 Aug 1;128(8):3490-3503. doi: 10.1172/JCI94524. Epub 2018 Jul 16. J Clin Invest. 2018. PMID: 30010623 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous